1. Home
  2. AGBK vs COLL Comparison

AGBK vs COLL Comparison

Compare AGBK & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AGI Inc Class A Common Shares

AGBK

AGI Inc Class A Common Shares

N/A

Current Price

$5.88

Market Cap

1.1B

Sector

Finance

ML Signal

N/A

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$22.53

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGBK
COLL
Founded
1999
2002
Country
Brazil
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2025
2015

Fundamental Metrics

Financial Performance
Metric
AGBK
COLL
Price
$5.88
$22.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$17.20
★ $51.40
AVG Volume (30 Days)
155.2K
★ 848.5K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $780,567,000.00
Revenue This Year
N/A
$8.01
Revenue Next Year
$235.22
N/A
P/E Ratio
$46.19
★ N/A
Revenue Growth
N/A
★ 23.62
52 Week Low
$5.73
$21.65
52 Week High
$12.21
$50.79

Technical Indicators

Market Signals
Indicator
AGBK
COLL
Relative Strength Index (RSI) 32.42 32.19
Support Level N/A $21.65
Resistance Level $7.42 $35.33
Average True Range (ATR) 0.21 0.89
MACD -0.07 0.30
Stochastic Oscillator 10.14 40.85

Price Performance

Historical Comparison
AGBK
COLL

About AGBK AGI Inc Class A Common Shares

AGI Inc is a technology-powered provider of specialized financial services in Brazil. It empowers clients to access their social security benefits, severance fund benefits, and public or private sector payrolls through secured lending solutions and complementary banking, credit and insurance products tailored as per client needs. The company has one operating segment related to the banking business. The Bank provides a standardized set of financial products and services exclusively to individuals, mainly focused on credit, including digital accounts, cards, payroll and personal loans, and insurance offered through partners.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: